Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Samsung Bioepis
Pharma
Regeneron loses bid to block Amgen's Eylea biosim, sinking shares
After a federal judge blocked the entry of two biosimilars for Eylea, the same judge has rejected Regeneron's bid to block Amgen’s Eylea knockoff.
Kevin Dunleavy
Sep 24, 2024 10:32am
Samsung Biologics' 37% sales surge propelled by biosimilars
Jul 24, 2024 10:56am
Humira's market share slips as biosimilars start to catch on
Jul 12, 2024 11:51am
Italy opens antitrust case against Novartis, Biogen and others
Jun 6, 2024 11:39am
Samsung Biologics achieves record Q1 earnings
Apr 30, 2024 9:09am
WuXi, Daiichi-Novartis, Merck KGaA-Abbisko—Fierce Pharma Asia
Dec 8, 2023 8:13am
